Skip to main content
. 2016 Jan 4;6:18691. doi: 10.1038/srep18691

Table 2. Cytotoxicity in cell culture lines induced by different treatments.

CELL LINE TREATMENTS LDH Estimates
P-values (***)
Mean (*) Var (**) LP LP-CC6 LP-CC24 CisPt
DU145 LP 18.2 0.367 1.000 1.000 1.000
LP-CC6 54.2 0.108 0.000 0.000 0.000
LP-CC24 36.0 0.369 1.000 0.000 0.003
CisPt 32.0 0.056 0.997 1.000 0.000
A2780 LP 4.0 0.095 1.000 1.000 1.000
LP-CC6 85.0 0.067 0.000 0.000 0.000
LP-CC24 54.0 0.032 0.000 1.000 0.000
CisPt 34.0 0.805 0.000 1.000 1.000
MCF-7 LP 22.0 0.036 1.000 1.000 0.990
LP-CC6 73.0 0.042 0.000 0.002 0.000
LP-CC24 68.0 0.334 0.000 0.998 0.000
CisPt 25.0 0.771 0.010 1.000 1.000
A375 LP 4.5 0.032 1.000 1.000 1.000
LP-CC6 38.0 0.411 0.000 0.002 0.004
LP-CC24 33.6 0.005 0.000 0.998 0.972
CisPt 35.0 0.543 0.000 0.996 0.028
HuH-7 LP 2.0 0.705 1.000 0.999 1.000
LP-CC6 69.0 0.060 0.000 0.000 0.000
LP-CC24 32.0 0.532 0.000 1.000 0.000
CisPt 10.0 0.155 0.001 1.000 1.000
PaTu- 8902 LP 6.5 0.008 1.000 1.000 1.000
LP-CC6 34.0 0.512 0.000 1.000 1.000
LP-CC24 46.0 0.478 0.000 0.000 0.996
CisPt 49.0 0.538 0.000 0.000 0.004
MCF-10A LP 22.0 0.402 0.992 0.999 1.000
LP-CC6 24.0 0.307 0.008 0.995 1.000
LP-CC24 26.0 0.245 0.001 0.005 0.999
CisPt 30.0 0.219 0.000 0.000 0.001

Table 2 shows the cytotoxic activity exerted by synthetic LP-CC6, LP-CC24 and CisPt alone and illustrates the mean level estimates of LDH based on the following triplicate treatments of cell lines. The hexapeptide showed more significant activity, except in PaTu-8902 cells, with a noticeable peak in ovarian (85.0%), breast (73.0%) and hepatocellular carcinoma cells (69.0%).

The data were obtained from 3 independent observations (the bars indicate the s.d.). The mean level estimates of LDH (cytotoxic effect) in the cell lines treated with LP, LP-CC6, LP-CC24 and CisPt;(N = 3).

*Sample mean and **unbiased estimate of the population variance. ***based on Welch’s test for the null hypothesis that the mean level of uptake for the treatment in the row is less or equal to the mean level of uptake for the treatment in the column, against the alternative that the former is greater than the latter.